parkinson-disease

Documents about parkinson-disease

• Cross-national disparities in end-of-life outcomes and care strategies for Parkinson's disease: a systematic review and meta-analysis of China and the United States.#156754NCBI PubMed Central
• Same evidence, different methodological choices: how six regulators dealt with paraquat and its links to Parkinson's disease#348928OSF
• Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: The ORCHESTRA Study#397209Springer Nature OA
• Freezing of gait and the effects of vibrotactile cueing in Parkinson's disease-a study protocol of a cross-sectional multimodal brain imaging approach in virtual walking scenarios.#399560NCBI PubMed Central
• Quercetin nanoparticles exhibit a potential therapeutic effect against the neurochemical changes and motor deficits in a rat model of Parkinson's disease#651761Europe PMC
• ATR 1072 in Participants With PRKAG2 Syndrome#804100ClinicalTrials.gov
• [18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients#836539ClinicalTrials.gov
• The efficacy and safety of precision repetitive transcranial magnetic stimulation in alleviating motor symptoms in Parkinson's disease (PRESS-PD): a randomized, double-blind, multicenter, placebo-controlled trial.#159986NCBI PubMed Central
• Investigation of correlation between cholesterol intake, apolipoprotein B and Parkinson’s disease related genes in guinea pigs feeding a high-fat diet containing cholesterol#313071PLOS
• Multi-centre randomised controlled feasibility trial with embedded process evaluation of a samba percussion intervention for people living with Parkinson's disease: a protocol for the Sparky Samba trial.#685527NCBI PubMed Central
• A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies#828717ClinicalTrials.gov
• The Effects of Digital Health Interventions on Motor Symptoms, Nonmotor Symptoms, and Quality of Life in Patients With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials.#160041NCBI PubMed Central
• A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Preliminary results of a mixed methods randomized controlled trial.#275360NCBI PubMed Central
• “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation#106079PhilArchive
• Caffeine-derived compounds as multifunctional neuroprotective agents: antioxidant activity in subcellular models and MAO-A/B inhibition#191006ARPHA OAI-PMH Endpoint
• Curcumin, Coenzyme-Q10, and Bioactive Compounds in Ashwagandha Extract: Multi-Targeting Potential of Co-Administered Natural Health Compounds as Therapeutic and Preventative Interventions in Alzheimer's and Parkinson's Disease Models.#319061NCBI PubMed Central
• The Disjunction Between ‘Not Likely’ and ‘Convincingly Demonstrated’: Statutory Safety Criteria and the APVMA’s 2026 Paraquat Assessment#355603OSF
• Table 1_Case Report: Deep brain stimulation in SYNJ1-related early-onset parkinsonism.docx#361739Figshare
• Table 2_Case Report: Deep brain stimulation in SYNJ1-related early-onset parkinsonism.xlsx#361740Figshare
• Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).#457540NCBI PubMed Central
• Loss of serotonergic function in carriers of PRKN mutations: a [<sup>11</sup>C]DASB PET study#205494Europe PMC
• Supplementary Material for: Synergistic neuroprotective effects of cortex of Albizia julibrissin Durazzini and stems and branches of Uncariae rhynchophylla (Miq.) Miq. in models of 6-OHDA-induced Parkinson’s disease#307789Figshare
• Macroscale gradient‐informed neural oscillation topography in Parkinson's disease / Hao Ding, Ke Xie, Manuel Bange, Hannah Kühne, Jenny Blech, Bahman Nasseroleslami, Jens Volkmann, Sergiu Groppa, Muthuraman Muthuraman#783952Deutsche Nationalbibliothek
• Harmonized Acquisition of Connectome MRI and Clinical Data for Stroke, Parkinson's Disease and Glioma: Delphi‐Derived Protocol Recommendations by the European Academy of Neurology#784446Europe PMC
• A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA#844776ClinicalTrials.gov
• A multicentre study on grey matter morphometric biomarkers for classifying early schizophrenia and parkinson's disease psychosis.#453975Apollo
• Physiological Investigations of Movement Disorders#831462ClinicalTrials.gov
• Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders#840159ClinicalTrials.gov
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results#7388OpenAlex
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson’s disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies#130449Unpaywall
• Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-based Therapy of Parkinson’s Disease#288293HAL (France)
• Park-MOVE - fNIRS study of complex walking in Parkinson's disease#369436api.researchdata.se
• Effectiveness of deep brain stimulation (DBS) surgery and its clinical outcomes among parkinson disease patients in Hospital Universiti Sains Malaysia (HUSM)#447630USM Repository
• PET Scan to Study Brain Control of Human Movement#861233ClinicalTrials.gov
• Intranasal delivery of dodecyl creatine ester alleviates motor deficits and increases dopamine levels in a 6-OHDA rat model of parkinsonism#417983HAL (France)
• Enhancement of Quality of Work And Life#805868ClinicalTrials.gov
• Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa#841611ClinicalTrials.gov
• Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa#861335ClinicalTrials.gov
• Context-dependent effects of rosmarinic acid on SH-SY5Y neurite morphology using a label-free, Parkinson’s disease-oriented image analysis workflow#324543ARPHA OAI-PMH Endpoint
• Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions#846388ClinicalTrials.gov
• From quantification to classification: comparative analysis of two software applications for machine learning–based prediction of early Parkinson’s disease using ^123I-Ioflupane metrics#233624Springer Nature OA
• Combined Vitamin D and Resveratrol Treatment Attenuates Motor Deficits and Neurodegeneration in a 6-OHDA Mouse Model of Parkinson's Disease in Male Mice: A Focus on Sirt1 and Lingo-1 Pathways in the Ventral Tegmental Area.#465039NCBI PubMed Central
• Elucidating the role of post-translational modifications of alpha-synuclein using semisynthesis : phosphorylation at Tyrosine 125 and monoubiquitination at Lysine 6#320072DataCite
• Microneedle-Based Continuous Levodopa Monitoring in Patients with Parkinson’s Disease#683881eScholarship
• Long-lasting concordance between imaging-guided and clinical-based STN-DBS programming enhances motor and axial outcomes in Parkinson's disease: A 3-year single-center study#642343Europe PMC
• Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization#440504Figshare
• Transition dynamics modeling of pre-trained accelerometry representations for time to diagnosis of Parkinson’s disease#425902Springer Nature OA
• Design and Development of Peptide Inhibitors Targeting Alpha-Synuclein for Parkinson’s Disease#246148DigitalCommons@Kennesaw State University
• Psychiatric side effects of bilateral monopolar high frequency stimulation or stimulation at the ventro-medial part of the subthalamic nucleus in patients with parkinson's disease#451864Figshare
• Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process#634696eScholarship